ctrl K

Amylyx Pharmaceuticals In... (AMLX)

NASDAQ: AMLX · Real-Time Price · USD

5.14

0.03 (0.59%)

At close: May 01, 2025, 3:59 PM

5.35

3.98%

After-hours: May 01, 2025, 07:13 PM EDT

Amylyx Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	87.37M	380.79M	22.23M	285K	650K	1.43M
Cost of Revenue	42.16M	25.44M	2.99M	52K	24.59M	11.9M
Gross Profit	45.22M	355.35M	19.24M	233K	-23.94M	-10.47M
Operating Income	-314.73M	38.8M	-201.34M	-82.69M	-39.01M	-13.55M
Interest Income	13.81M	16.16M	4.29M	36K	14K	176K
Pretax Income	-302.14M	54.3M	-197.6M	-87.93M	-42.28M	-13.72M
Net Income	-301.74M	49.27M	-198.38M	-87.88M	-44.84M	-14.82M
Selling & General & Admin	114.33M	188.36M	127.13M	38.93M	15.06M	3.08M
Research & Development	104.08M	128.19M	93.45M	44.04M	24.59M	11.9M
Other Expenses	141.53M	n/a	3.74M	-285K	-650K	-1.43M
Operating Expenses	359.95M	316.54M	220.58M	82.69M	39.01M	13.55M
Interest Expense	n/a	n/a	4.29M	n/a	2.29M	1.28M
Selling & Marketing Expenses	n/a	9.5M	4.4M	n/a	n/a	n/a
Cost & Expenses	402.1M	341.98M	223.57M	82.69M	39.01M	13.55M
Income Tax Expense	-393K	5.03M	774K	-52K	2.56M	1.1M
Shares Outstanding (Basic)	68.14M	67.23M	66.51M	57.86M	56.47M	56.47M
Shares Outstanding (Diluted)	68.14M	69.99M	66.51M	57.86M	56.47M	56.47M
EPS (Basic)	-4.43	0.73	-2.98	-1.52	-0.79	-0.26
EPS (Diluted)	-4.43	0.70	-2.98	-1.52	-0.79	-0.26
EBITDA	-301.23M	39.89M	-200.85M	-82.64M	-39M	1.11M
EBIT	-291.88M	38.8M	-201.34M	-82.69M	-39.01M	-12.44M
Depreciation & Amortization	904K	1.09M	487K	52K	1K	13.55M